Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	411.33	358.71	310.46	331.34	391.87
Revenue Growth (YoY)	14.67%	15.54%	-6.30%	-15.45%	16.35%
Cost of Revenue	77.38	36.6	42.64	13.79	-
Gross Profit	333.94	322.11	267.82	317.55	391.87
Selling, General & Admin	113.32	115.69	98.23	63.54	16.19
Depreciation & Amortization Expenses	26.28	25.9	21.78	5.58	-
Research & Development	30.6	13.65	33.92	41.43	0.58
Operating Income	163.75	166.87	113.89	207	375.1
Interest Income	-21.09	-19.14	-15.82	6.37	1.84
Interest Expense	16.7	22.21	19.16	-15.79	-19.07
Other Non-Operating Income (Expense)	164.46	-120.42	93.49	395.95	-94.66
Total Non-Operating Income (Expense)	160.07	-117.35	96.83	386.53	-111.89
Pretax Income	326.86	37.39	194.1	286.95	445.28
Provision for Income Taxes	-55.7	-14	-14.38	66.69	76.44
Net Income	271.17	23.39	179.72	213.92	265.85
Minority Interest in Earnings	-	-	-	6.34	102.98
Net Income to Common	271.17	23.39	179.72	213.92	265.85
Net Income Growth	1059.22%	-86.98%	-15.99%	-19.53%	18.47%
Shares Outstanding (Basic)	67	63	65	70	82
Shares Outstanding (Diluted)	85	74	87	95	94
Shares Change (YoY)	14.25%	-14.61%	-8.79%	1.00%	-16.95%
EPS (Basic)	4.02	0.37	2.75	3.07	3.24
EPS (Diluted)	3.30	0.36	2.20	2.37	2.87
EPS Growth	816.67%	-83.64%	-7.17%	-17.42%	42.08%
Free Cash Flow	195.8	188.42	140.65	201.66	363.81
Free Cash Flow Growth	3.92%	33.96%	-30.25%	-44.57%	16.20%
Free Cash Flow Per Share	2.31	2.54	1.62	2.12	3.86
Gross Margin	81.19%	89.80%	86.27%	95.84%	100.00%
Operating Margin	39.81%	46.52%	36.68%	62.47%	95.72%
Profit Margin	65.92%	6.52%	57.89%	66.48%	94.12%
FCF Margin	47.60%	52.53%	45.30%	60.86%	92.84%
EBITDA	203.97	206.72	149.59	226.51	388.94
EBITDA Margin	49.59%	57.63%	48.18%	68.36%	99.25%
EBIT	163.75	166.87	113.89	207	375.1
EBIT Margin	39.81%	46.52%	36.68%	62.47%	95.72%
Effective Tax Rate	-17.04%	-37.43%	-7.41%	23.24%	17.17%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q